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Abstract 
New stable dicarboxylate phosphabetaines were synthesized by the phosphorylation of a series of 
unsaturated carboxylic acids. Interaction of 3-(diphenylphosphonio)propionic acid with 
unsaturated monocarboxylic acids leads to formation of stable dicarboxylate phosphabetaines 1-
7. The structure of the isolated compounds was determined by IR and NMR spectroscopy, X-ray 
single crystal diffraction studies and elemental analysis. Their thermal stability was studied by 
simultaneous thermogravimetry and differential scanning calorimetry. All of the synthesized 
compounds were tested for their antibacterial and anti-Candida activity. 
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GRAPHICAL ABSTRACT 
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INTRODUCTION 
 Organophosphorus compounds are one of the most important groups of modern 
antimicrobial agents, due to their high antifungal and antibacterial activity
1-3
. Various types of 
organophosphorus compounds have been synthesized and their biological activities have been 
tested
4-6
. Herewith we report on the synthesis, structure and biological activity of new stable 
dicarboxylate phosphabetaines. 
RESULTS AND DISCUSSION 
We previously described the syntheses of various phosphabetaines from tertiary 
phosphines and unsaturated mono- and dicarboxylic acids and the results of their structural 
assessment and reactivity studies
7-16
.  
 
In the present work we synthesized new stable dicarboxylate phosphabetaines on the basis 
of unsaturated monocarboxylic acids. As a phosphorylating agent we used 3-(diphenyl-
phosphonio)propanoic acid because it contains not only a tertiary phosphorus atom, but also a 
carboxylic group. Interaction of 3-(diphenylphosphonio)propionic acid with unsaturated mono-
carboxylic acids leads to formation of stable dicarboxylate phosphabetaines 1-7.  
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The reactions of 3-(diphenylphosphonio)propionic acid with unsaturated monocarboxylic 
acids in ethylacetate or acetonitrile are complete within 1 day and form the target betaines 1-7 as 
white crystals in 67-80% yields. All of the synthesized compounds were characterized by 
31
P 
NMR and IR spectroscopy as well as by their melting point and elemental analysis (Tables 1 and 
2). Their thermal stability was studied by simultaneous thermogravimetry and differential 
scanning calorimetry (Figure 1).  
Thermogravimetry and differential scanning calorimetry of phosphabetaine 1 revealed a 
high thermal stability. The TG-DSC curve (Figure 1) shows a well-defined endothermic effect 
with its maximum at 236 °C, which is associated with a weight loss. The decomposition of 
phosphabetaine 1 involves water and CO2 release. The absence of weight loss in the range 30-
226 °C is indicative of a high thermal stability of this compound. 
The structure of the dicarboxylate phosphabetaines obtained has been confirmed by physical 
methods, including X-ray single crystal diffraction for two compounds 2 and 5 (Figures 2 and 3). 
X-ray data show that these betaine structures are stabilized in the crystalline phase by 
intermolecular hydrogen bonding. 
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The biological activity of dicarboxylate phosphabetaines has been studied (Table 3). 
The antibacterial and antifungal activity of a series of dicarboxylate phosphabetaines 
were investigated in vitro against several pathogenic representative Gram-negative bacteria 
(Pseudomonas aeruginoza ATCC 27853 and Escherichia coli ATCC 25922), Gram-positive 
bacteria (Staphylococcus aureus ATCC 29213 and Bacillus cereus ATCC 11778), and 
pathogenic fungi Candida albicans ATCC 885-653. The results are summarized in Table 3.  
Cup-plate Agar method was used for evaluation of antibacterial activity. The nutrient 
agar medium was used. The medium with bacteria was poured into sterilized Petri dishes under 
aseptic conditions. Standard drugs were Chlorohexidine (50 µg/0.1 mL) and test compounds at 
concentration of 50 µg/0.1 mL. The solvent used was a mixture of water and isopropanol at 
different ratios (1:10). Plates were incubated at 37 °C for 24 hours. The antifungal activity was 
carried out by using cup-plate method using Sabouraud’s agar medium. The standard drug used 
was Griseofulvin (50 µg/0.1 mL) and the test compounds at concentration of 50 µg/0.1 mL by 
using of the mixture of the solvents ethanol and water at different ratios (1:10). After incubation 
the average of inhibition was recorded in mm. 
The synthesized compounds exhibited moderate antimicrobial activities in vitro. 
Especially, compounds 6 and 7 showed the most potent antibacterial and antifungal activities.  
CONCLUSIONS 
New dicarboxylate phosphabetaines were synthesized and their structures were 
determined by IR, NMR, TG-DSC and X-ray single crystal diffraction. The antimicrobial 
activity was measured. We have also reported the first crystal structures of these compounds.  
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EXPERIMENTAL 
All chemicals purchased from Sigma-Aldrich were reagent grade and used without 
purification. All organic solvents were dried and freshly distilled before use.  
The 
31
P NMR spectra (CDCl3) were registrated with a Bruker Avance-400 instrument. The 
IR spectra were obtained on an IR Prestige-21 instrument in the range 400-3700 cm
-1
 in mineral 
oil or in thin film between KBr plates. Thermal stability was studied using a Netzsch Jupiter 
STA 449C microthermoanalyzer for simultaneous thermogravimetric analysis and differential 
scanning calorimetry, coupled with a Netzsch QMS 403C Aeolos mass spectrometer; the 
samples were heated at a rate of 10 deg/min in an argon atmosphere. Microanalytical data were 
provided by the Microanalytical Laboratory, A.E. Arbuzov Institute of Organic and Physical 
Chemistry, Russian Academy of Sciences, Kazan.  
General Procedure for the Synthesis of Dicarboxylate Phosphabetaines 1-7 
A mixture of equimolar amounts of 3-(diphenylphosphonio)propionic acid and unsaturated 
monocarboxylic acids in dry ethyl acetate or acetonitrile was stirred at room temperature for 6 h, 
when the solid precipitated after the reduction of the volume of the solvent. The separated 
precipitate was filtered off, washed several times with diethyl ether and dried in vacuum over 
CaCl2.  
Single Crystal X-ray Diffraction Studies 
A data set for a single crystal of compound 2 was collected with a Bruker AXS 
Kappa APEX Duo diffractometer with graphite-monochromated Mo-K radiation (λ = 
0.71073 Å). Programs used: data collection APEX2
17
, data reduction SAINT
18
, 
absorption correction SADABS version 2.10
19
, structure solution SHELXT
19
, structure 
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refinement by full-matrix least-squares against F
2
 using SHELXL
20
. Hydrogen atoms 
were placed into calculated positions and refined as riding atoms, except the hydrogen of 
the carboxyl group which was located from a difference Fourier map and refined 
isotropically. The figures were generated using Mercury 3.1 programs
21
. The hydrogen 
atom is disordered over two carboxyl groups and was refined with an occupancy ratio of 
0.5. 
Crystal data for 2: formula C19H21O4P, crystal size 0.27 × 0.18 × 0.12 mm
3
, Mr = 
344.33, monoclinic, space group C2/c, a = 16.323(4), b = 9.162(2), c = 23.005(6) Å, β = 
91.327(6)°, V = 3439.5(15) Å
3, Z = 8, ρc = 1.330 g/cm
3, μ = 0.179 mm−1, T = 150(2) K, θ 
range = 1.771° to 30.526°, reﬂections collected 38918; independent: 5244 (R int = 0.0637) 
and 3631 observed reflections [I >2 (I)], 227 refined parameters, R1 = 0.0500, wR2 = 
0.0621 [I >2σ(I)]; maximal residual electron density: 0.73/-0.59 e Å−3. 
Crystallographic data for the structural analysis of compound 2 has been deposited at the 
Cambridge Crystallographic Data Center (CCDC number 1485737). Copies of the information 
may be obtained free of charge from The Director, CCDC, 12 Union Road, Cambridge CB2 1 
EZ, UK (Fax: + 44-1223-336033; email: deposit@ccdc.cam.ac.uk or www.ccdc.can.ac.uk). 
A data set for a single crystal of C24H22ClO4P 5 were obtained with an automatic Bruker 
Smart APEX II CCD diffractometer [(MoK) = 0.71073 Å, -scanning]. Programs used: data 
collection APEX2
17
, data reduction SAINT
18
, structure solution SHELXS97
19
, structure 
refinement by full-matrix least-squares against F
2
 using SHELXL-97
19
.  
Crystal data for C24H22ClO4P, M = 440.84 g/mol, monoclinic, space group P21/n (No. 14), 
Z = 4, a = 10.024(6), b = 16.711(10), c = 16.279(10) Å, β = 104.850(6)º, V = 2636(3) Å3, ρcalc = 
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1.111 gcm-3, μ = 0.229 mm-1, multi-scan absorption correction was applied using SADABS20, 
21148 reflections collected (h, k, l), θ range = 1.80 to 27.00, 5739 independent (Rint = 0.094) 
and 2589 observed reflections [I  2 (I)], 279 refined parameters, R = 0.1177, wR2 = 0.3849, 
max. residual electron density 0.86 (-0.71) e Å
-3
. R-factors are high because of the weakly 
diffracting small crystal. 
Crystallographic data for the structural analysis of compound 2 has been deposited at the 
Cambridge Crystallographic Data Center (CCDC number 1487431). Copies of the information 
may be obtained free of charge from The Director, CCDC, 12 Union Road, Cambridge CB2 1 
EZ, UK (Fax: + 44-1223-336033; email: deposit@ccdc.cam.ac.uk or www.ccdc.can.ac.uk). 
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Table 1. Selected IR data, 
31Р NMR chemical shifts and melting points for the dicarboxylate 
phosphabetaines 1-7 
 
 
Compound 
Selected IR 
data (cm
-1
) 
ν(COO-) / 
ν(COOH) 
δ31Р 
(ppm) 
m.p. 
(°C) 
1 
3-((2-carboxyethyl)-
diphenylphosphonio)propanoate 
1680 28.4 221 
2 
3-((2-carboxyethyl)-
diphenylphosphonio)butanoate 
1630/1710 35.0 176 
3 
3-((2-carboxyethyl)-
diphenylphosphonio)-2-
methylpropanoate 
1620/1680 27.1 79 
4 
3-((2-carboxyethyl)-
diphenylphosphonio)-3-
phenylpropanoate 
1590/1700 31.2 193 
5 
3-((2-carboxyethyl) 
diphenylphosphonio)-3-(4-
chlorophenyl)propanoate 
1540/1620 30.3 157.3 
6 
3-((2-carboxyethyl) 
diphenylphosphonio)-3-(3,5-lb-
tert-butyl-4-
hydroxyphenyl)propanoate 
1550/1680 32.4 196.7 
7 
3-((2-carboxyethyl) 
diphenylphosphonio)-3-
(thiophen-2-yl)propanoate 
1660/1700 35.0 182.4 
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Table 2. Physical data for the dicarboxylate phosphabetaines 1-7 
Compound 
Mw 
(g/mol) 
Yield 
(%) 
Empirical 
formula 
Found (Calcd) (%) 
C H P 
1 330 81 C18H19PO4 
66.27 
(65.45) 
5.50 
(5.85) 
9.09 
(9.39) 
2 344 74 C19H21PO4 
65.43 
(65.30) 
5.34 
(5.50) 
8.84 
(8.76) 
3 344 67 C19H21PO4 
69.48 
(69.70) 
5.19 
(5.13) 
7.76 
(7.89) 
4 406 76 C24H23PO4 
70.10 
(70.40) 
5.34 
(5.66) 
7.95 
(7.64) 
5 440.5 65 C24H22PO4Cl 
64.50 
(65.38) 
4.54 
(4.99) 
6.56 
(7.03) 
6 412 70 C22H21PO4S 
63.96 
(64.88) 
5.09 
(4.87) 
7.52 
(7.58) 
7 534 49 C32H39PO5 
71.80 
(71.91) 
6.94 
(7.30) 
5.42 
(5.80) 
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Table 3. Antifungal and bactericidal activity of dicarboxylate phosphabetaines 6 and 7  
(growth inhibition zone, mm) of compounds (c = 50 µg/0.1 mL) 
Compound 
Zone of inhibition, d (mm) 
E. coli 
Bacillus 
cereus 
Ps. 
aeruginosa 
S. 
aureus 
Candida 
albicans 
6 12 9 7 13 18 
7 10 6 6 11 15 
Chlorohexidin
e 
11 8 9 17 15 
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Figure 1. TG/DSC analysis data phosphabetaine 1  
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Figure 2. Molecular structure of 2,3-((1-carboxypropan-2-
yl)diphenylphosphonio)propanoate in the crystal 
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Figure 3. Molecular structure of 5,3-((2-carboxy-1-(4-
chlorophenyl)ethyl)diphenylphosphonio)propanoate in the crystal  
 
